Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Capital Expenditures: 2021-2025

Historic Capital Expenditures for Biofrontera (BFRI) over the last 3 years, with Sep 2025 value amounting to -$1,000.

  • Biofrontera's Capital Expenditures was N/A to -$1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$37,000, marking a year-over-year change of. This contributed to the annual value of $10,000 for FY2024, which is 100.00% up from last year.
  • As of Q3 2025, Biofrontera's Capital Expenditures stood at -$1,000, which was down 200.00% from $1,000 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Capital Expenditures registered a high of $57,000 during Q1 2024, and its lowest value of -$40,000 during Q4 2024.
  • For the 3-year period, Biofrontera's Capital Expenditures averaged around $2,250, with its median value being $0 (2025).
  • As far as peak fluctuations go, Biofrontera's Capital Expenditures slumped by 1,000.00% in 2023, and later skyrocketed by 307.14% in 2024.
  • Quarterly analysis of 5 years shows Biofrontera's Capital Expenditures stood at $9,000 in 2021, then slumped by 88.89% to $1,000 in 2022, then crashed by 1,000.00% to -$9,000 in 2023, then slumped by 344.44% to -$40,000 in 2024, then skyrocketed by 114.29% to -$1,000 in 2025.
  • Its last three reported values are -$1,000 in Q3 2025, $1,000 for Q2 2025, and $3,000 during Q1 2025.